Agentix Corp. (AGTX) stock
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$0.02+0.00 (0.00%)
Close on Oct 16, 2026Market cap $801.34KP/E –Yield –
Agentix EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Agentix's EPS for the twelve months ending Jun 30, 2026 was $0.00. For fiscal 2026 it was -$0.01. The highest annual figure on record is -$0.01 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$0.01 | – |
| FY2025 | Mar 31, 2025 | -$0.01 | – |
| FY2024 | Mar 31, 2024 | -$0.01 | – |
| FY2021 | Aug 31, 2021 | -$0.04 | – |
| FY2019 | Aug 31, 2019 | -$6.45 | – |
| FY2018 | Aug 31, 2018 | -$3875.40 | – |
| FY2017 | Aug 31, 2017 | -$32.22 | – |
| FY2016 | Aug 31, 2016 | -$26.85 | – |
| FY2015 | Aug 31, 2015 | -$16.11 | – |
| FY2014 | Aug 31, 2014 | -$21.48 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $0.00 | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $0.00 | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $0.00 | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $0.00 | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $0.00 | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $0.00 | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $0.00 | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $0.00 | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $0.00 | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $0.00 | – |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | -$0.01 | – |
| Q3 FY2021CQ2 2021 | May 31, 2021 | $0.00 | – |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | -$0.02 | – |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | -$0.01 | – |
| Q3 FY2020CQ2 2020 | May 31, 2020 | -$0.38 | – |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | -$0.09 | – |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | -$0.42 | – |
| Q3 FY2019CQ2 2019 | May 31, 2019 | -$0.03 | – |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | -$0.04 | – |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | -$2.20 | – |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | -$1.52 | – |
| Q3 FY2018CQ2 2018 | May 31, 2018 | -$3742.86 | – |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | -$5.37 | – |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | -$5.37 | – |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | -$5.07 | – |
| Q3 FY2017CQ2 2017 | May 31, 2017 | -$5.37 | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | -$5.37 | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | -$10.74 | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | -$10.26 | – |
| Q3 FY2016CQ2 2016 | May 31, 2016 | -$16.11 | – |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | $0.00 | – |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | $0.00 | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | -$2.25 | – |
| Q3 FY2015CQ2 2015 | May 31, 2015 | $0.00 | – |
| Q2 FY2015CQ1 2015 | Feb 28, 2015 | -$5.37 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?